USA - NASDAQ:FBRX - US34962G2084 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to FBRX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-18 | Guggenheim | Initiate | Buy |
| 2025-08-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-24 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-21 | TD Cowen | Initiate | Buy |
| 2024-12-04 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-30 | Brookline Capital | Initiate | Buy |
| 2024-04-08 | Ladenburg Thalmann | Upgrade | Neutral -> Buy |
| 2021-09-20 | Chardan Capital | Upgrade | Sell -> Neutral |
| 2021-09-03 | Chardan Capital | Downgrade | Buy -> Sell |
| 2021-09-03 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2021-09-03 | Brookline Capital | Downgrade | Buy -> Hold |
| 2021-09-03 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2021-09-03 | Truist Securities | Downgrade | Buy -> Hold |
| 2021-05-14 | B. Riley Securities | Initiate | Buy |
| 2021-03-26 | Citigroup | Initiate | Buy |
| 2021-03-17 | Chardan Capital | Maintains | Buy |
11 analysts have analysed FBRX and the average price target is 53.3 USD. This implies a price increase of 311.86% is expected in the next year compared to the current price of 12.94.
The consensus rating for FORTE BIOSCIENCES INC (FBRX) is 83.6364 / 100 . This indicates that analysts generally have a positive outlook on the stock.